Only 2-4 healthy messages per week can have a positive impact….

Is diagnosis of type 2 more dangerous in youth?…

Studies have shown that, on average, 54% of patients experience some type of error in medication reconciliation in the hospital. This leads to all kinds of problems as often these patients are prescribed hospital meds with no way to know if possible drug interactions will occur. Imagine if you could …

  In this week’s Homerun Slides, we continue our series from Dr. Stanley Schwartz, with a focus on some of the treatments drugs including metformin, pioglitazone, and the glp-1 agonists….

Anne Peters, MD, and Lori Laffel, MD, MPH, Editors Jane Lee Chiang, MD, Managing Editor Continuous Subcutaneous Insulin Infusion (CSII) PEDIATRICS David Maahs, MD, PhD, and H. Peter Chase, MD Standard of Care A consensus statement on the use of insulin pump therapy, CSII, in youth with type 1 diabetes (T1D) …

Monthly Prescribing Reference $5.99 iOS/$5.99 Android    The Drugs & Bugs app by Monthly Prescribing Reference (MPR) is an essential resource for allied healthcare professionals, clinicians, and residents who care for patients with infectious diseases. It is also a useful reference guide for students receiving clinical training. It provides comprehensive, …

As we come to the holiday season there is a lot to be thankful for but some people are going to have a lot better Christmas than others. These "lucky schemers" have figured out a way to make millions by defrauding the Medicare Part D dry plan. A report released …

Bristol-Myers Squibb Selling Global Diabetes Business  Bristol-Myers Squibb is selling its global diabetes business which includes the blockbuster drugs Byetta, Bydureon, and Onglyza, to AstraZeneca. 

PROTECT iT – The Intelligent Texture Sock    Therapeutic diabetic socks help to relieve discomfort, provide warmth, and prevent bacterial growth. PROTECT iT, the "Intelligent Texture" sock has multi-zone construction providing increased protection for sore-prone areas with silver ions within the fibers to inhibit bacterial growth, fungus and odor.   

According to updated analyses of the effects of weight-loss surgery from 164 studies, following 161,756 patients aged about 46 with a BMI of 46, BMI loss five years after surgery ranged from 12% to 17%, complication rates ranged from 10% to 17%, and the reoperation rate was about 7%. Among …